Jane Street’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5K Buy
+14,600
New +$17.8K ﹤0.01% 11214
2025
Q4
Sell
-12,800
Closed -$16.1K 11535
2025
Q3
$16.1K Buy
+12,800
New +$13.8K ﹤0.01% 10555
2023
Q3
Sell
-10,100
Closed -$48.1K 8843
2023
Q2
$48.1K Buy
+10,100
New +$55.7K ﹤0.01% 8216
2022
Q4
Sell
-36,400
Closed -$816K 9415
2022
Q3
$816K Buy
36,400
+12,300
+51% +$355K ﹤0.01% 5803
2022
Q2
$597K Buy
24,100
+3,500
+17% +$96.6K ﹤0.01% 6420
2022
Q1
$799K Sell
20,600
-55,200
-73% -$2.14M ﹤0.01% 6588
2021
Q4
$4.43M Buy
75,800
+68,700
+968% +$3.89M 0.01% 3044
2021
Q3
$421K Buy
7,100
+900
+15% +$70.6K ﹤0.01% 7595
2021
Q2
$538K Sell
6,200
-5,800
-48% -$467K ﹤0.01% 7091
2021
Q1
$989K Buy
12,000
+8,700
+264% +$834K ﹤0.01% 5482
2020
Q4
$300K Buy
+3,300
New +$205K ﹤0.01% 6418
2020
Q3
Sell
-8,900
Closed -$305K 7376
2020
Q2
$305K Buy
+8,900
New +$265K ﹤0.01% 5806

Other funds holding FATE